Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Galbincea

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Science|June 19, 2010
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assaysC Cameron Yin, Jorge Cortes, John Galbincea, et al.
Cancer Genetics and Cytogenetics|February 2, 2010
Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutationsLaura Millecker, Patrick A Lennon, Srdan Verstovsek, et al.
The American Journal of Surgical Pathology|May 8, 2013
High-level microsatellite instability in appendiceal carcinomasMelissa W Taggart, John Galbincea, Paul F Mansfield, et al.
Virchows Archiv : an International Journal of Pathology|July 18, 2014
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencingAlberto Paniz-Mondolfi, Rajesh Singh, George Jour, et al.
Human Pathology|March 17, 2016
BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 casesKhaled Alayed, L Jeffrey Medeiros, Keyur P Patel, et al.
Virchows Archiv : an International Journal of Pathology|January 27, 2015
Cutaneous carcinosarcoma and the EMT: to transition, or not to transition? That is the questionAlberto Paniz-Mondolfi, Rajesh Singh, George Jour, et al.
American Journal of Clinical Pathology|October 22, 2015
Clinical validation of a multipurpose assay for detection and genotyping of CALR mutations in myeloproliferative neoplasmsMeenakshi Mehrotra, Rajyalakshmi Luthra, Rajesh R Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2009
Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal typeCarlos A Torres-Cabala, Wei-Lien Wang, Jonathan Trent, et al.
The Journal of Molecular Diagnostics : JMD|December 23, 2018
Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample CollectionKeyur P Patel, Roberto Ruiz-Cordero, Wei Chen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Science|June 19, 2010
Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assaysC Cameron Yin, Jorge Cortes, John Galbincea, et al.
Cancer Genetics and Cytogenetics|February 2, 2010
Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms with or without JAK2 or MPL mutationsLaura Millecker, Patrick A Lennon, Srdan Verstovsek, et al.
The American Journal of Surgical Pathology|May 8, 2013
High-level microsatellite instability in appendiceal carcinomasMelissa W Taggart, John Galbincea, Paul F Mansfield, et al.
Virchows Archiv : an International Journal of Pathology|July 18, 2014
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencingAlberto Paniz-Mondolfi, Rajesh Singh, George Jour, et al.
Human Pathology|March 17, 2016
BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 casesKhaled Alayed, L Jeffrey Medeiros, Keyur P Patel, et al.
Virchows Archiv : an International Journal of Pathology|January 27, 2015
Cutaneous carcinosarcoma and the EMT: to transition, or not to transition? That is the questionAlberto Paniz-Mondolfi, Rajesh Singh, George Jour, et al.
American Journal of Clinical Pathology|October 22, 2015
Clinical validation of a multipurpose assay for detection and genotyping of CALR mutations in myeloproliferative neoplasmsMeenakshi Mehrotra, Rajyalakshmi Luthra, Rajesh R Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2009
Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal typeCarlos A Torres-Cabala, Wei-Lien Wang, Jonathan Trent, et al.
The Journal of Molecular Diagnostics : JMD|December 23, 2018
Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample CollectionKeyur P Patel, Roberto Ruiz-Cordero, Wei Chen, et al.
Pageof 1